(Q53644116)

English

SEW2871 protects from experimental colitis through reduced epithelial cell apoptosis and improved barrier function in interleukin-10 gene-deficient mice.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

SEW2871 protects from experimental colitis through reduced epithelial cell apoptosis and improved barrier function in interleukin-10 gene-deficient mice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

author name string

Jianning Dong

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Honggang Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Jie Zhao

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Jing Sun

4

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Tenghui Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Lugen Zuo

6

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Weiming Zhu

7

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Jianfeng Gong

8

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Yi Li

9

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Lili Gu

10

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Jieshou Li

11

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

publication date

1 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Immunologic Research

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

61

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

303-311

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Importance of disrupted intestinal barrier in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Crohn's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10-/- mice.

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Tight junctions on the move: molecular mechanisms for epithelial barrier regulation

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Mouse models for the study of Crohn's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-γ production

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

The outs and the ins of sphingosine-1-phosphate in immunity

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice.

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure.

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury.

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Sphingosine 1-phosphate and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

An update on sphingosine-1-phosphate and other sphingolipid mediators

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Oral fingolimod (FTY720) for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Lactobacillus plantarum prevents the development of colitis in IL-10-deficient mouse by reducing the intestinal permeability

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Disrupted barrier function through epithelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8625-5

21 January 2018

New insights into the immunological changes in IL-10-deficient mice during the course of spontaneous inflammation in the gut mucosa.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25588868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10-/- mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/25588868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora

1 reference

https://pubmed.ncbi.nlm.nih.gov/25588868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner

1 reference

https://pubmed.ncbi.nlm.nih.gov/25588868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of the interleukin-10 knockout mouse model of colitis: antitumour necrosis factor-antibodies suppress the progression of colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25588868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/25588868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12026-015-8625-5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25588868

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53644116&oldid=2212245608"